Cost Curve

The Strangest ‘Member’ of the Pharmaceutical Reform Alliance, According to Curve Readers

And Americans from all political persuasions appear to agree on one thing: hatred of PBMs

Brian Reid

Hospitals Received $244 Billion for 340B Drugs Last Year, Pocketing $142 Billion in Profit

And I need your vote in a very, very important poll

Brian Reid

The CMS Rules Bringing International Prices to Medicare Are Essentially Meaningless

And a not-very-insightful launch price paper has a not-very-transparent funding source

Brian Reid

PhRMA Selects Its Next CEO: Former Congressional Heavyweight Eric Cantor

And companies with new meds are (again) getting shy about revealing prices at approval

Brian Reid

Seniors Probably Won’t Be Happy About 2027 Medicare Choices (Even Though CMS Is Celebrating Lower Premiums)

Plus 84 pages on what the Democrats will do on healthcare if they retake the House

Brian Reid

Hospital Billing Is Getting More Aggressive, Raising Costs. Insurers Are Blaming AI

Plus more data on the link -- or lack thereof -- between 340B revenue and charity care

Brian Reid

Does a New Analysis Comparing TrumpRx Prices to International Cash Prices Clarify Anything?

And a deep dive on 340B hospital financial assistance policies

Brian Reid

Keytruda, Opdivo Top a New Forecast of the 20 Drugs Due for Medicare ‘Negotiations’ Next Year

And Chris Klomp’s ducked MFN and TrumpRx questions from Senators; his nomination advances anyway

Brian Reid

Pfizer’s Bourla: CEOs Might Want to ‘Send Me Thank-You Notes’ for MFN Work

Brian Reid